Innovation Centers / Center for Molecular & Behavioral Neuroscience

Center for Molecular & Behavioral Neuroscience

Center for Molecular & Behavioral Neuroscience Administration Team

Clivel Charlton, PhD

Director, Center for Molecular and Behavioral Neuroscience & Professor
School of Medicine
Center for Molecular & Behavioral Neuroscience

(615) 327-6971
ccharlton@mmc.edu

Center for Molecular & Behavioral Neuroscience Research Team

Clivel Charlton, PhD

Director, Center for Molecular and Behavioral Neuroscience & Professor
School of Medicine
Center for Molecular & Behavioral Neuroscience

(615) 327-6971
ccharlton@mmc.edu

Center for Molecular & Behavioral Neuroscience Publications

Optogenetic-induced multimerization of the dopamine transporter increases uptake and trafficking to the plasma membrane.
Shalonda M Ingram, Tanu Rana, Ashley M Manson, Faisal M Yayah, Evan G B Jackson, Christopher Anderson, Benem-Orom Davids, J Shawn Goodwin

Small-Molecule Natural Product Physachenolide C Potentiates Immunotherapy Efficacy by Targeting BET Proteins.
Poonam Tewary, Alan D Brooks, Ya-Ming Xu, E M Kithsiri Wijeratne, Ashley L Babyak, Timothy C Back, Raj Chari, Christine N Evans, Curtis J Henrich, Thomas J Meyer, Elijah F Edmondson, Maria T Prudente de Aquino, Thanigaivelan Kanagasabai, Anil Shanker, A A Leslie Gunatilaka, Thomas J Sayers

Bortezomib Sustains T Cell Function by Inducing miR-155-Mediated Downregulation of SOCS1 and SHIP1.
Ariana N Renrick, Menaka C Thounaojam, Maria Teresa P de Aquino, Evan Chaudhuri, Jui Pandhare, Chandravanu Dash, Anil Shanker

Activation of proline biosynthesis is critical to maintain glutamate homeostasis during acute methamphetamine exposure.
Bobby Jones, Muthukumar Balasubramaniam, Joseph J Lebowitz, Anne Taylor, Fernando Villalta, Habibeh Khoshbouei, Carrie Grueter, Brad Grueter, Chandravanu Dash, Jui Pandhare

COVID-19 and Cancer Comorbidity: Therapeutic Opportunities and Challenges.
Anup S Pathania, Philip Prathipati, Bakrudeen Aa Abdul, Srinivas Chava, Santharam S Katta, Subash C Gupta, Pandu R Gangula, Manoj K Pandey, Donald L Durden, Siddappa N Byrareddy, Kishore B Challagundla

Phase II Study of Immunotherapy With Tecemotide and Bevacizumab After Chemoradiation in Patients With Unresectable Stage III Non-Squamous Non-Small-Cell Lung Cancer (NS-NSCLC): A Trial of the ECOG-ACRIN Cancer Research Group (E6508).
Jyoti D Patel, Ju-Whei Lee, David P Carbone, Henry Wagner, Anil Shanker, Maria Teresa P de Aquino, Leora Horn, Melissa L Johnson, David E Gerber, Jane Jijun Liu, Millie S Das, Mohammed Ali Al-Nsour, Christopher S R Dakhil, Suresh Ramalingam, Joan H Schiller